Literature DB >> 25267416

A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXL.

Stephen Brown, Brian Hutton, Tammy Clifford, Doug Coyle, Daniel Grima, George Wells, Chris Cameron1.   

Abstract

BACKGROUND: The use of network meta-analysis has increased dramatically in recent years. WinBUGS, a freely available Bayesian software package, has been the most widely used software package to conduct network meta-analyses. However, the learning curve for WinBUGS can be daunting, especially for new users. Furthermore, critical appraisal of network meta-analyses conducted in WinBUGS can be challenging given its limited data manipulation capabilities and the fact that generation of graphical output from network meta-analyses often relies on different software packages than the analyses themselves.
METHODS: We developed a freely available Microsoft-Excel-based tool called NetMetaXL, programmed in Visual Basic for Applications, which provides an interface for conducting a Bayesian network meta-analysis using WinBUGS from within Microsoft Excel. . This tool allows the user to easily prepare and enter data, set model assumptions, and run the network meta-analysis, with results being automatically displayed in an Excel spreadsheet. It also contains macros that use NetMetaXL's interface to generate evidence network diagrams, forest plots, league tables of pairwise comparisons, probability plots (rankograms), and inconsistency plots within Microsoft Excel. All figures generated are publication quality, thereby increasing the efficiency of knowledge transfer and manuscript preparation.
RESULTS: We demonstrate the application of NetMetaXL using data from a network meta-analysis published previously which compares combined resynchronization and implantable defibrillator therapy in left ventricular dysfunction. We replicate results from the previous publication while demonstrating result summaries generated by the software.
CONCLUSIONS: Use of the freely available NetMetaXL successfully demonstrated its ability to make running network meta-analyses more accessible to novice WinBUGS users by allowing analyses to be conducted entirely within Microsoft Excel. NetMetaXL also allows for more efficient and transparent critical appraisal of network meta-analyses, enhanced standardization of reporting, and integration with health economic evaluations which are frequently Excel-based.

Entities:  

Mesh:

Year:  2014        PMID: 25267416      PMCID: PMC4195340          DOI: 10.1186/2046-4053-3-110

Source DB:  PubMed          Journal:  Syst Rev        ISSN: 2046-4053


  21 in total

Review 1.  Bayesian methods in meta-analysis and evidence synthesis.

Authors:  A J Sutton; K R Abrams
Journal:  Stat Methods Med Res       Date:  2001-08       Impact factor: 3.021

2.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Authors:  Michael J Sweeting; Alexander J Sutton; Paul C Lambert
Journal:  Stat Med       Date:  2004-05-15       Impact factor: 2.373

3.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.

Authors:  Georgia Salanti; A E Ades; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2010-08-05       Impact factor: 6.437

4.  How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.

Authors:  Paul C Lambert; Alex J Sutton; Paul R Burton; Keith R Abrams; David R Jones
Journal:  Stat Med       Date:  2005-08-15       Impact factor: 2.373

Review 5.  Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons.

Authors:  Jeroen P Jansen; Bruce Crawford; Gert Bergman; Wiro Stam
Journal:  Value Health       Date:  2008-05-16       Impact factor: 5.725

6.  Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.

Authors:  Sylwia Bujkiewicz; Hayley E Jones; Monica C W Lai; Nicola J Cooper; Neil Hawkins; Hazel Squires; Keith R Abrams; David J Spiegelhalter; Alex J Sutton
Journal:  Value Health       Date:  2011-04-30       Impact factor: 5.725

Review 7.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Authors:  Deborah M Caldwell; A E Ades; J P T Higgins
Journal:  BMJ       Date:  2005-10-15

8.  Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution?

Authors:  Kristian Thorlund; Lehana Thabane; Edward J Mills
Journal:  BMC Med Res Methodol       Date:  2013-01-11       Impact factor: 4.615

9.  A Web-based archive of systematic review data.

Authors:  Stanley Ip; Nira Hadar; Sarah Keefe; Christopher Parkin; Ramon Iovin; Ethan M Balk; Joseph Lau
Journal:  Syst Rev       Date:  2012-02-21

10.  Characteristics of networks of interventions: a description of a database of 186 published networks.

Authors:  Adriani Nikolakopoulou; Anna Chaimani; Areti Angeliki Veroniki; Haris S Vasiliadis; Christopher H Schmid; Georgia Salanti
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  58 in total

Review 1.  Interventions for Refractory Trigeminal Neuralgia: A Bayesian Mixed Treatment Comparison Network Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Kannan Sridharan; Gowri Sivaramakrishnan
Journal:  Clin Drug Investig       Date:  2017-09       Impact factor: 2.859

2.  Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Gwan Gyu Song; Young Ho Lee
Journal:  Clin Drug Investig       Date:  2019-05       Impact factor: 2.859

3.  Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Authors:  Sang-Cheol Bae; Young Ho Lee
Journal:  Clin Rheumatol       Date:  2018-02-05       Impact factor: 2.980

4.  Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2017-12       Impact factor: 1.372

5.  Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.

Authors:  Khagendra Dahal; Aditya Hendrani; Sharan P Sharma; Sampath Singireddy; George Mina; Pratap Reddy; Paari Dominic; Kalgi Modi
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

6.  Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2015-05-21       Impact factor: 2.631

7.  Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Authors:  S-C Bae; Y H Lee
Journal:  Z Rheumatol       Date:  2019-08       Impact factor: 1.372

8.  Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials.

Authors:  Kannan Sridharan; Gowri Sivaramakrishnan
Journal:  Br J Clin Pharmacol       Date:  2018-01-05       Impact factor: 4.335

9.  Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Y H Lee; S-C Bae
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

10.  Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Authors:  Sang-Cheol Bae; Young Ho Lee
Journal:  Clin Rheumatol       Date:  2018-02-01       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.